Author

M. Stanczak

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Gikandi· 1 shared A. J. Aguirre· 1 shared A. S. Chandhoke· 1 shared B. Małachowska· 1 shared D. A. Scott· 1 shared J. D. Mancias· 1 shared M. Kuljanin· 1 shared M. P. Jedrychowski· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Gikandi

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivSep 14, 2019

Defining and targeting adaptations to oncogenic KRASG12C inhibition using quantitative temporal proteomics

N. Santana-Codina, A. S. Chandhoke, Q. Yu…·J. D. Mancias

This study uses quantitative temporal proteomics to analyze KRASG12C inhibitor responses in cancer models, identifying effective drug combinations to overcome resistance.

DOI 10.1016/j.celrep.2020.03.021

humanproteomics

𝕏 PostBluesky